OHI on XNYS, Real Estate, Omega Healthcare Investors Inc., job postings
Measures activity, not value. Not investment advice.
Net income rose 41% to $761.8M over 12 months, but a revenue line fell 90% to $30.8M.
WatchQuarterly revenue up 9.3% to $340.6M, at odds with the 90% drop
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
expected around 3 Feb 2027 (an estimate: a year ago it reported on 4 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $340.6M, net income $83.1M.
31 Dec 2021RevenueNet incometallest bar $362.8M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$340.6M
$83.1M
30 Jun 2026
$328.2M
$362.8M
31 Mar 2026
$323.0M
$151.0M
31 Dec 2025
$319.2M
$164.8M
30 Sep 2025
$311.6M
$179.7M
30 Jun 2025
$282.5M
$136.6M
31 Mar 2025
$276.8M
$109.0M
31 Dec 2024
$279.3M
$116.5M
30 Sep 2024
$276.0M
$114.9M
30 Jun 2024
$252.7M
$117.1M
31 Mar 2024
$243.3M
$69.3M
31 Dec 2023
$239.3M
$56.5M
30 Sep 2023
$242.0M
$93.9M
30 Jun 2023
$250.2M
$61.5M
31 Mar 2023
$218.2M
$36.8M
31 Dec 2022
$144.8M
$46.7M
30 Sep 2022
$239.4M
$105.1M
30 Jun 2022
$244.6M
$91.9M
31 Mar 2022
$249.3M
$195.2M
31 Dec 2021
$249.9M
$34.2M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$1.3B
$1.2B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+14%
+5.2%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$761.8M
$541.8M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$2.48
$1.79
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
68.4%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
37.9%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
58.1%
47.1%
14.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
14.5%
4.4%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$776.9M
$807.2M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$195.9M
$737.2M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
$5.0B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
$4.3B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
1.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$18.09
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
18.2
24.5
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
10.6
4.5
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
9.8
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
2.5
1.1
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
5.9%
5.1%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+2.7%
763 13F filers vs 743
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
82%
249.3M shares held by 13F filers (30 Sep 2026) of 304.3M outstanding (30 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
4.8%
14.8M shares sold short (30 Oct 2026) of 304.3M outstanding (30 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
7.6
14.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-1.9%
15.1M shares sold short in the report before, 14.8M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
61%
61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+9.3%
$340.6M vs $311.6M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+16%
$24.6M vs $21.2M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
20
20 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.7×
20 articles in the last 7 days; its usual week has 3.
Unusual now sharp changes in the last 90 days, compared with its own past
Revenue $30.8M, -90% vs a year earlier
Price $45.53 on 20 Nov 2026, +2.1% over 12 months (12-month range $42.93 to $51.72)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $1.3M).Revenue per quarter. Revenue $340.6M in the latest quarter, +9.3% on a year earlier.Capital spending per quarter. Capital spending $24.6M in the latest quarter, +16% on a year earlier.Institutional holders (13F filers). 763 13F filers reported holding it in the latest 13F quarter, +19% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.
Changes and notable records, by the date each became public
5 Nov 2026Financials change
reported revenue of $30.8M for the quarter ended 30 Sep 2026, 90% below the same quarter last year.
Same quarter last year: $311.6M; its normal quarter is $278.1M.
See the evidence
This period
$30.8M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$278.1M
Typical spread (median absolute deviation)
$19.0M
How far from its usual level
-8.8
Same quarter last year
$311.6M
History used
3,470 days
the quarter ended 30 Sep 20268 earlier quartersnormal: $278.1M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $14.0M for the quarter ended 30 Jun 2026, 95% below the same quarter last year.
Same quarter last year: $282.5M; its normal quarter is $278.1M.
See the evidence
This period
$14.0M (the quarter ended 30 Jun 2026)
Normal quarter (median of 8 earlier)
$278.1M
Typical spread (median absolute deviation)
$14.9M
How far from its usual level
-9.5
Same quarter last year
$282.5M
History used
3,378 days
the quarter ended 30 Jun 20268 earlier quartersnormal: $278.1M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $6.7M for the quarter ended 31 Mar 2026, 98% below the same quarter last year.
Same quarter last year: $276.8M; its normal quarter is $278.1M.
See the evidence
This period
$6.7M (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
$278.1M
Typical spread (median absolute deviation)
$14.9M
How far from its usual level
-9.8
Same quarter last year
$276.8M
History used
3,287 days
the quarter ended 31 Mar 20268 earlier quartersnormal: $278.1M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
saw 75 13F filers open a new position in the quarter ended 30 Jun 2025, 1.1× the same quarter last year.
Same quarter last year: 71; its normal quarter is 51.5.
See the evidence
This period
75 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
51.5
Typical spread (median absolute deviation)
4
How far from its usual level
+4.0
Same quarter last year
71
History used
4,291 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 51.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
spent $20.2M on capital projects in the quarter ended 31 Mar 2025, 2.9× the same quarter last year.
Same quarter last year: $6.9M; its normal quarter is $8.1M.
See the evidence
This period
$20.2M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$8.1M
Typical spread (median absolute deviation)
$1.6M
How far from its usual level
+5.1
Same quarter last year
$6.9M
History used
5,661 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $8.1M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
reported revenue of $144.8M for the quarter ended 31 Dec 2022, 42% below the same quarter last year.
Same quarter last year: $249.9M; its normal quarter is $253.7M.
See the evidence
This period
$144.8M (the quarter ended 31 Dec 2022)
Normal quarter (median of 8 earlier)
$253.7M
Typical spread (median absolute deviation)
$9.6M
How far from its usual level
-4.3
Same quarter last year
$249.9M
History used
2,101 days
the quarter ended 31 Dec 20228 earlier quartersnormal: $253.7M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 16.6M shares sold short in the 30 Nov 2021 report, 2.0× the same report last year.
Same report last year: 8.2M; its normal report is 9.4M.
See the evidence
This period
16.6M (the 30 Nov 2021 report)
Normal report (median of 24 earlier)
9.4M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
8.2M
History used
1,432 days
the 30 Nov 2021 report24 earlier reportsnormal: 9.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 15.0M shares sold short in the 15 Nov 2021 report, 1.8× the same report last year.
Same report last year: 8.2M; its normal report is 9.2M.
See the evidence
This period
15.0M (the 15 Nov 2021 report)
Normal report (median of 24 earlier)
9.2M
Typical spread (median absolute deviation)
1.0M
How far from its usual level
+3.7
Same report last year
8.2M
History used
1,417 days
the 15 Nov 2021 report24 earlier reportsnormal: 9.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 11.4M shares sold short in the 15 Jul 2021 report, 1.4× the same report last year.
Same report last year: 7.9M; its normal report is 8.0M.
See the evidence
This period
11.4M (the 15 Jul 2021 report)
Normal report (median of 24 earlier)
8.0M
Typical spread (median absolute deviation)
625K
How far from its usual level
+3.6
Same report last year
7.9M
History used
1,294 days
the 15 Jul 2021 report24 earlier reportsnormal: 8.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 11.1M shares sold short in the 30 Jun 2021 report, 1.3× the same report last year.
Same report last year: 8.2M; its normal report is 8.0M.
See the evidence
This period
11.1M (the 30 Jun 2021 report)
Normal report (median of 24 earlier)
8.0M
Typical spread (median absolute deviation)
586K
How far from its usual level
+3.5
Same report last year
8.2M
History used
1,279 days
the 30 Jun 2021 report24 earlier reportsnormal: 8.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 82 entries; narrow the window or the kind of data to see older ones.
Not listed: 181 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000888491
Ticker
OHI
Domain
omegahealthcare.com
Employer name
Omega Healthcare Investors, Inc. (1 unverified)
Fein
38-3041398 (1 unverified)
Hq location
MD|HUNT VALLEY|21030 (1 unverified)
Name
476.O, Omega Healthcare Investors Inc.
DOL H-1B labor condition applications and PERM certifications2 data points24 Mar 2025 to 24 Mar 2025
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)154 records7 Jan 2016 to 4 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)863 data points31 Dec 2007 to 30 Oct 2026
SEC Form 4 insider transactions85 records, 300 data points16 Feb 2016 to 6 Nov 2025
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026